![]() ElectroCore ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders. | ![]() ReShape Lifesciences ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. | ||
Founding Date | Founding Date 2005 | Founding Date 2002 | Founding Date 2002 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Rockaway, US HQ Parksville, CA Geretsried, DE Hamburg, DE Yeadon, GB Bernards, US | Locations San Carlos, US HQ | Locations San Clemente, US HQ San Clemente, US |
Employees | Employees 5144% decrease | Employees 2713% increase | Employees 4348% decrease |
Valuation ($) | Valuation ($) 71.2 m | Valuation ($) 8.5 m | Valuation ($) 3 m |
Financial | |||
Revenue (est.) | Revenue (est.) $32m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $11.3m (FY, 2020) |
Cost of goods | Cost of goods $4.2m (FY, 2025) | Cost of goods N/A | Cost of goods $5m (FY, 2020) |
Gross profit | Gross profit $27.8m (FY, 2025) | Gross profit N/A | Gross profit $6.3m (FY, 2020) |
Net income | Net income ($14m) (FY, 2025) | Net income ($8.2m) (FY, 2025) | Net income ($21.6m) (FY, 2020) |

BioCardia is a clinical-stage regenerative medicine company.
View company
ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
View company